Holen Sie sich die Stockscreener-App
11.06
3.66%
-0.42
Handel nachbörslich:
11.01
-0.05
-0.45%
Schlusskurs vom Vortag:
$11.48
Offen:
$11.41
24-Stunden-Volumen:
667.64K
Relative Volume:
1.66
Marktkapitalisierung:
$381.81M
Einnahmen:
$85.23M
Nettoeinkommen (Verlust:
$2.70M
KGV:
176.11
EPS:
0.0628
Netto-Cashflow:
$20.97M
1W Leistung:
+0.36%
1M Leistung:
+10.16%
6M Leistung:
+28.31%
1J Leistung:
-25.47%
1-Tages-Spanne:
$11.04
$11.62
1-Wochen-Bereich:
$10.82
$12.27
52-Wochen-Spanne:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
11.06 | 396.31M | 85.23M | 2.70M | 20.97M | 0.0628 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
TradingKey - TradingKey
Delcath Systems Q1 2026: -$0.03 EPS Tops Estimates — Deep Dive - AlphaStreet
Tangible book value per share of Delcath Systems, Inc. – SWB:DV3R - TradingView
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Delcath Systems (NASDAQ:DCTH) Announces Quarterly Earnings Results - MarketBeat
Delcath Systems Balances Growth with Rising Costs - TipRanks
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
MSN Money - MSN
Delcath Systems, Inc. (DCTH) Stock Analysis: Aiming for an 89.80% Upside in the Medical Device Sector - DirectorsTalk Interviews
Uveal Melanoma Treatment Market is expected to Hit US$ 2.7 - openPR.com
Delcath Systems (DCTH) Trailing Profitability Flip Tests Bullish Margin Expansion Narrative - Sahm
Delcath Systems Reports First Quarter 2026 Results and Business Highlights - BioSpace
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 - BioSpace
Number of shareholders of Delcath Systems, Inc. – DUS:DV3R - TradingView
Delcath Systems Q1 Earnings Call Highlights - MarketBeat
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Earnings call transcript: Delcath Systems Q1 2026 beats EPS forecast, stock rises - Investing.com
Delcath Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
DCTH: Q1 saw record patient starts, 36% volume growth, and strong 2026 revenue guidance - TradingView
Delcath presents data on liver cancer treatment in breast cancer patients By Investing.com - Investing.com South Africa
Delcath presents data on liver cancer treatment in breast cancer patients - Investing.com UK
Delcath Systems Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Delcath Systems (NASDAQ:DCTH) Surpasses Q1 Estimates, Guidance Points to Continued Growth - ChartMill
Delcath Systems (NASDAQ: DCTH) grows Q1 2026 sales but posts small loss - Stock Titan
DELCATH SYSTEMS ($DCTH) Releases Q1 2026 Earnings - Quiver Quantitative
Delcath (NASDAQ: DCTH) Q1 revenue hits $25M with 2026 outlook of $100M+ - Stock Titan
Delcath Systems Sees Positive Adjusted EBITDA for 2026 >DCTH - Moomoo
Cancer treatment company targets $100M sales with 29 centers active - Stock Titan
A liver-targeted breast cancer procedure drew new data at ESMO - Stock Titan
Delcath Systems Q1 2026 Earnings Call Transcript - MarketBeat
Delcath Systems Q1 2026 earnings preview - MSN
Trading Systems Reacting to (DCTH) Volatility - Stock Traders Daily
Earnings Preview: DCTH to Report Financial Results Pre-market on May 07 - Moomoo
How The Delcath Systems (DCTH) Story Is Shifting With Hepzato Milestones And 2026 Guidance - Yahoo Finance
Delcath Systems (DCTH) to Release Quarterly Earnings on Thursday - MarketBeat
Delcath Systems (DCTH) Q2 2025 earnings summary - Quartr
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
BlackRock (NASDAQ: DCTH) holds 1.73M DELCATH shares, 4.98% - Stock Titan
Implied volatility surging for Delcath Systems stock options - MSN
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Delcath Systems to Host First Quarter 2026 Earnings Call - BioSpace
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates - MSN
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):